Heron Therapeutics (HRTX) Stock Price
$2.2 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Heron Therapeutics, AI stock picks, stock alerts and much more.
HRTX AI Stock Analysis
AI stock analysis for HRTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Heron Therapeutics (HRTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Heron Therapeutics (HRTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Heron Therapeutics (HRTX), currently trading at $2.2, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About HRTX
-
Heron Therapeutics, Inc.
-
Symbol
HRTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
335.6M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.46 0.1% |
6 |
 |
Inovio Pharmaceuticals INO |
$1.33 37.9% |
3 |
 |
Moderna MRNA |
$30.49 0.7% |
3 |
 |
Anavex Life Sciences AVXL |
$10.79 2.1% |
7 |
 |
BridgeBio Pharma BBIO |
$43.99 2.7% |
7 |
News
HRTX Alternative Data
Web Traffic
Heron Therapeutics receives an estimated 13556 monthly visitors to herontx.com.
-
Web Traffic
13556
-
Change from Previous Month
141.8%
-
3 Month Change
116.5%
-
YoY Change
116.5%
LinkedIn Followers
15,025 are following Heron Therapeutics on LinkedIn, up by 0.9% over the last month.
-
LinkedIn Followers
15025
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
3%
Job Postings
Heron Therapeutics currenly has an estimated 9 open job postings, up by 28.6% over the last month.
-
Job Postings
9
-
Daily Change
0%
-
1 Month Change
28.6%
-
3 Month Change
28.6%
-
YoY Change
28.6%
LinkedIn Employees
According to LinkedIn, Heron Therapeutics has 182 employees, up by 3.4% over the last month.
-
LinkedIn Employees
182
-
Daily Change
0%
-
1 Month Change
3.4%
-
3 Month Change
2.2%
-
YoY Change
2.2%
Reddit Mentions
Heron Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Heron Therapeutics is 27 out of 100 (bearish).
-
Business Outlook
27
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Heron Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
HRTX Financials
HRTX Key Metrics
-
Total Revenue
$40.8M
-
Net Income
$3.7M
-
Earnings per Share
$0.0239
-
Free cash flow
-$12.4M
-
EBITDA
$8.7M
-
EBITDA Ratio
0.214168
-
Total Assets
$233.1M
HRTX 2-year Revenue & Income
HRTX 2-year Free Cash Flow
HRTX Technicals
HRTX SMA
HRTX RSI
FAQ
What's the current price of Heron Therapeutics (HRTX) Stock?
The price of an Heron Therapeutics (HRTX) share is $2.2.
What's the market cap of Heron Therapeutics?
The current market cap of Heron Therapeutics is 335.6M.
Should I buy or sell HRTX?
Heron Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Heron Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Heron Therapeutics a good investment?
The current analysis of Heron Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Heron Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Heron Therapeutics (HRTX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Heron Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Heron Therapeutics (HRTX) that investors often compare it to?
Heron Therapeutics (HRTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Heron Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Heron Therapeutics' stock price to be around $2.13 in 2026. Starting from the current price of $2.2, this represents a 3.3% change in price, indicating a neutral outlook for the stock.
How to buy Heron Therapeutics (HRTX) Stock?
Heron Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Heron Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.